BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22519443)

  • 1. Myocardial structure and matrix metalloproteinases.
    Aggeli C; Pietri P; Felekos I; Rautopoulos L; Toutouzas K; Tsiamis E; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1113-31. PubMed ID: 22519443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial extracellular matrix remodeling in ischemic heart failure.
    Gallagher GL; Jackson CJ; Hunyor SN
    Front Biosci; 2007 Jan; 12():1410-9. PubMed ID: 17127391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variability of matrix metalloproteinase genes in cardiovascular disease.
    Papageorgiou N; Tousoulis D; Hatzis G; Briasoulis A; Androulakis E; Giolis A; Siasos G; Latsios G; Vogiatzi G; Tentolouris C; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1206-13. PubMed ID: 22519450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial proteases and cardiac remodeling.
    Riaz S; Zeidan A; Mraiche F
    J Cell Physiol; 2017 Dec; 232(12):3244-3250. PubMed ID: 28255990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributory role of matrix metalloproteinases in cardiovascular remodeling.
    Gunasinghe SK; Ikonomidis J; Spinale FG
    Curr Drug Targets Cardiovasc Haematol Disord; 2001 Dec; 1(2):75-91. PubMed ID: 12769658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling.
    Manso AM; Elsherif L; Kang SM; Ross RS
    Cardiovasc Res; 2006 Feb; 69(3):574-84. PubMed ID: 16253214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
    Lindsey ML; Iyer RP; Jung M; DeLeon-Pennell KY; Ma Y
    J Mol Cell Cardiol; 2016 Feb; 91():134-40. PubMed ID: 26721597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
    Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
    Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases.
    Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
    Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their function in myocardium.
    Kukacka J; Průsa R; Kotaska K; Pelouch V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):225-36. PubMed ID: 16601761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial proteases and matrix remodeling in inflammatory heart disease.
    Rutschow S; Li J; Schultheiss HP; Pauschinger M
    Cardiovasc Res; 2006 Feb; 69(3):646-56. PubMed ID: 16417902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix modulation and heart failure: new concepts question old beliefs.
    Deschamps AM; Spinale FG
    Curr Opin Cardiol; 2005 May; 20(3):211-6. PubMed ID: 15861009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.